Doctors address the pros and cons of Health Resources and Services Administration’s new guidance, including at-home ...

For stable, symptomatic patients with suspected CAD who are deemed to be at “minimal risk” using a CT-based tool, deferral of diagnostic testing is just as safe as the usual approach and is even ...

Approximately 80 percent of patients who have the hepatitis C virus may have been missed through EMR-reliant risk-based testing, according to research from the CDC. The paper, published in Clinical ...

Cascade genetic risk evaluation in families with hereditary cancer can reduce the burden of disease but the rate of germline genetic testing in relatives of patients at risk is low. We identified all ...

A prospective trial of gastrointestinal cancer patients showed the feasibility of preemptive genetic testing for DPYD/UGT1A1 variants associated with increased chemotherapy toxicity. Genotype-guided ...